Waterfront Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,361
Closed -$648K 250
2023
Q2
$648K Buy
1,361
+403
+42% +$186K 0.19% 148
2023
Q1
$441K Buy
958
+105
+12% +$50K 0.14% 168
2022
Q4
$420K Sell
853
-702
-45% -$356K 0.14% 173
2022
Q3
$831K Sell
1,555
-31
-2% -$14.8K 0.32% 93
2022
Q2
$765K Buy
1,586
+592
+60% +$293K 0.31% 92
2022
Q1
$517K Buy
+994
New +$454K 0.18% 126

Other funds holding ELV

Waterfront Wealth's ELV Position: Q3 2023 in Review

Waterfront Wealth sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 1,361 shares — an estimated $648K sold.

Waterfront Wealth first reported a position in ELV in Q1 2022 and held it in 6 quarters. The position peaked at $831K in Q3 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • Waterfront Wealth reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
  • Waterfront Wealth sold 1,361 Elevance Health shares in Q3 2023, an estimated $648K.
  • Waterfront Wealth first reported a position in Elevance Health in Q1 2022 and held it in 6 quarters.
  • Waterfront Wealth's Elevance Health position peaked at $831K in Q3 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Waterfront Wealth's 13F filing for Q3 2023, filed 9 Nov 2023.